ScreenerHero
GABAGabather AB
STO · SE · Healthcare · Drug Manufacturers - Specialty & Generic · gabather.com
0.0316SEK-3.66%Mkt Cap: 1.85M $P/E: —

Gabather AB (publ), a pharmaceutical company, develops drug candidates for the treatment of central nervous system diseases. It offers drugs primarily in the areas of anti-psychotics, anti-depressants and anxiolytics, an…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
MERCK Kommanditgesellschaft auf Aktien
$65.24BUSDP/E 23.7
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$43.41BUSDP/E 20.1
ZOE
Zoetis Inc.
$29.37BUSDP/E 12.4
UTHR
United Therapeutics Corporation
$22.70BUSDP/E 19.0
VTRS
Viatris, Inc.
$18.66BUSD
SOBI
Swedish Orphan Biovitrum AB
$15.39BUSDP/E 118.0
NBIX
Neurocrine Biosciences, Inc.
$15.81BUSDP/E 22.8
IPN
Ipsen S.A.
$14.67BUSDP/E 26.5
ELAN
Elanco Animal Health Incorporat
$12.24BUSD
KRK
Krka, d. d.
$8.57BUSDP/E 18.8
HIMS
Hims & Hers Health, Inc.
$7.25BUSD
LQDA
Liquidia Corporation
$6.74BUSDP/E 53.8
LNTH
Lantheus Holdings Inc
$6.56BUSDP/E 24.0
AMRX
Amneal Pharmaceuticals, Inc.
$6.23BUSDP/E 37.3
INDV
Indivior PLC Ordinary Shares
$4.61BUSDP/E 14.0
HIK
Hikma Pharmaceuticals PLC
$4.32BUSDP/E 12.5
AMLX
Amylyx Pharmaceuticals Inc. Common Stock
$4.30BUSD
SFZN
Siegfried Holding AG
$3.91BUSDP/E 20.4
ROVI
Laboratorios Farmaceuticos Rovi, S.A.
$3.34BUSDP/E 16.6
SUPN
Supernus Pharmaceuticals, Inc.
$2.82BUSD

Key Statistics

Company
Market Cap1.85M $
Enterprise Value1.27M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-444.97K $
Revenue/Share—
Last Price0.0316 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINSE0010869552
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B6.32
EPS (TTM)-0.01
EPS (Forward)—
52W Range
0.023011% of range0.1000
52W High0.1000 SEK
52W Low0.0230 SEK
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-702.72%
ROA-86.87%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-690.99K $
CapEx (TTM)—
FCF Margin—
FCF Yield-24.91%
Net Debt-577.45K $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio1.66
Quick Ratio1.58
Book Value/Sh0.0050 SEK
Cash/Share0.0100 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:4
Split DateMar 22, 2018
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.610.49M
Float610.49M
Insiders9.05%
Institutions6.69%
Technical
SMA 500.0344 (-8.1%)
SMA 2000.0357 (-11.5%)
Beta-0.77
S&P 52W Chg18.16%
Avg Vol (30d)2.59M
Avg Vol (10d)2.43M
Technical Indicators
RSI (14)45.9
MACD-0.0004
MACD Signal-0.0006
MACD Hist.+0.0002
BB Upper0.0364 SEK
BB Middle0.0320 SEK
BB Lower0.0275 SEK
BB Width28.00%
ATR (14)0.0039 SEK
Vol Ratio (20d)1.00x